Customize your JAMA Network experience by selecting one or more topics from the list below.
Since October 3, 2001, CDC and state and local public health authorities have been investigating cases of bioterrorism-related anthrax.1-5 As of November 28, a total of 23 cases have been identified; 11 were confirmed as inhalational anthrax, and 12 (seven confirmed and five suspected) were cutaneous. Epidemiologic investigations to identify the source of exposure to Bacillus anthracis continue for a case of inhalational anthrax in a hospital stockroom worker in New York City (NYC) and, most recently, a case of inhalational anthrax in an elderly woman in Connecticut (CT). Antimicrobial prophylaxis is continuing in persons exposed to B. anthracis, and surveillance to detect new cases of bioterrorism-related anthrax is ongoing. This report summarizes the findings of the case investigation in CT.
Update: Investigation of Bioterrorism-Related Inhalation Anthrax—Connecticut, 2001. JAMA. 2001;286(23):2936–2937. doi:https://doi.org/10.1001/jama.286.23.2936-JWR1219-2-1
Create a personal account or sign in to: